Prevalence of MASLD, MetALD, ALD and liver fibrosis in patients with type 2 diabetes in 30,199 subjects in the general population: insights from the LiverScreen cohort

Conference Reports for NATAP

EASL - European Association
for the Study of the Liver
Barcelona, Spain
May 27-30, 2026


Prevalence of MASLD, MetALD, ALD and liver fibrosis in patients with type 2 diabetes in 30,199 subjects in the general population: insights from the LiverScreen cohort

	EASL 2026 May 26-30 Barcelona Laurent Castera1, G Pera2,